Abstract
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney and brain have continued to propel tumor classification and precision therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 113-114 |
| Number of pages | 2 |
| Journal | Journal of Pathology and Translational Medicine |
| Volume | 56 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2022 |
All Science Journal Classification (ASJC) codes
- Pathology and Forensic Medicine
- Histology
Fingerprint
Dive into the research topics of 'What’s new in molecular genetic pathology 2022: Immune checkpoint inhibitor biomarkers and select solid tumors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver